Brighton Jones LLC Sarepta Therapeutics, Inc. Transaction History

Brighton Jones LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 07, 2018	SELL	$115.31 - $161.51 $540,227 - $756,674	-4,685 Closed	0 $0
Q2 2018 Aug 06, 2018	BUY	$71.74 - $153.69 $573 - $1,229	8 Added 0.17%	4,685 $619,000
Q1 2018 May 03, 2018	BUY	$54.02 - $82.27 $864 - $1,316	16 Added 0.34%	4,677 $347,000
Q3 2017 Nov 08, 2017	BUY	$35.73 - $47.15 $166,537 - $219,766	4,661	4,661 $211,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Brighton Jones LLC, based on Form 13F filings with the SEC.

Stay updated on Brighton Jones LLC with notifications on news.